Variant report

Variant	esv3315501
Chromosome Location	chr17:16718327-16726625
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:67)
CpG islands
(count:0)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:67 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:16719169-16719457	K562	blood:	n/a	n/a
2	BACH1	chr17:16719341-16719384	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr17:16722231-16722357	NHEK	skin:	n/a	n/a
4	CTCF	chr17:16719216-16719498	NHEK	skin:	n/a	n/a
5	CTCF	chr17:16722180-16722330	A549	lung:	n/a	n/a
6	CTCF	chr17:16719553-16719585	Kidney_OC	kidney:	n/a	n/a
7	CTCF	chr17:16719240-16719390	HMEC	breast:	n/a	n/a
8	CTCF	chr17:16722198-16722382	MCF-7	breast:	n/a	n/a
9	CTCF	chr17:16719334-16719455	Pancreas_OC	pancreas:	n/a	n/a
10	CTCF	chr17:16722282-16722309	GM12878	blood:	n/a	n/a
11	CTCF	chr17:16722187-16722392	MCF-7	breast:	n/a	n/a
12	CTCF	chr17:16722197-16722371	MCF-7	breast:	n/a	n/a
13	CTCF	chr17:16722127-16722443	K562	blood:	n/a	n/a
14	CTCF	chr17:16722258-16722375	LNCaP	prostate:	n/a	n/a
15	CTCF	chr17:16719220-16719370	HMEC	breast:	n/a	n/a
16	CTCF	chr17:16721980-16722130	K562	blood:	n/a	n/a
17	CTCF	chr17:16722218-16722341	A549	lung:	n/a	n/a
18	CTCF	chr17:16722269-16722281	GM12878	blood:	n/a	n/a
19	CTCF	chr17:16725222-16725241	GM13976	blood:	n/a	n/a
20	CTCF	chr17:16726027-16726055	LNCaP	prostate:	n/a	n/a
21	CTCF	chr17:16722261-16722310	GM12892	blood:	n/a	n/a
22	CTCF	chr17:16722203-16722355	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr17:16722139-16722407	K562	blood:	n/a	n/a
24	CTCF	chr17:16722175-16722391	MCF-7	breast:	n/a	n/a
25	CTCF	chr17:16722200-16722350	K562	blood:	n/a	n/a
26	CTCF	chr17:16722140-16722290	MCF-7	breast:	n/a	n/a
27	CTCF	chr17:16722240-16722327	Fibrobl	skin:	n/a	n/a
28	CTCF	chr17:16722280-16722298	Hela-S3	cervix:	n/a	n/a
29	CTCF	chr17:16722180-16722330	MCF-7	breast:	n/a	n/a
30	CTCF	chr17:16722200-16722350	AG09309	skin:	n/a	n/a
31	CTCF	chr17:16722160-16722310	WERI-Rb-1	eye:	n/a	n/a
32	CTCF	chr17:16722128-16722338	A549	lung:	n/a	n/a
33	CTCF	chr17:16719921-16719989	GM13976	blood:	n/a	n/a
34	CTCF	chr17:16726160-16726218	GM20000	blood:	n/a	n/a
35	CTCF	chr17:16719394-16719507	LNCaP	prostate:	n/a	n/a
36	CTCF	chr17:16722127-16722348	K562	blood:	n/a	n/a
37	CTCF	chr17:16722865-16722935	GM13976	blood:	n/a	n/a
38	CTCF	chr17:16722260-16722410	HCFaa	heart:	n/a	n/a
39	CTCF	chr17:16719240-16719390	HCT-116	colon:	n/a	n/a
40	CTCF	chr17:16722203-16722363	GM12891	blood:	n/a	n/a
41	CTCF	chr17:16722168-16722385	K562	blood:	n/a	n/a
42	CTCF	chr17:16719360-16719510	NHEK	skin:	n/a	n/a
43	CTCF	chr17:16719200-16719350	HEEpiC	esophagus:	n/a	n/a
44	CTCF	chr17:16720520-16720577	GM12892	blood:	n/a	n/a
45	CTCF	chr17:16722017-16722517	K562	blood:	n/a	n/a
46	CTCF	chr17:16722178-16722395	MCF-7	breast:	n/a	n/a
47	CTCF	chr17:16725354-16725421	Kidney_OC	kidney:	n/a	n/a
48	CTCF	chr17:16719220-16719370	SAEC	small airway:	n/a	n/a
49	CTCF	chr17:16722260-16722410	HBMEC	blood vessel:	n/a	n/a
50	CTCF	chr17:16722227-16722361	LNCaP	prostate:	n/a	n/a

No data

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:16721818..16722353-chr17:16776583..16777108,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000226145	TF binding region

Extended variants
information (count: 353 )
Associated
traits (count: 158 )

Variant overlapped rSNPs/rCNVs (count:353 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536718076	chr17:16718397-16718398	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
2	rs71362272	chr17:16718399-16718400	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs570158660	chr17:16718400-16718401	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
4	rs8079406	chr17:16718432-16718433	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs538830737	chr17:16718441-16718442	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
6	rs558766617	chr17:16718453-16718454	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
7	rs572400199	chr17:16718456-16718457	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
8	rs541325451	chr17:16718461-16718462	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
9	rs554507481	chr17:16718484-16718485	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
10	rs75506892	chr17:16718528-16718529	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
11	rs35089195	chr17:16718529-16718530	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
12	rs75497081	chr17:16718530-16718531	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
13	rs397758727	chr17:16718540-16718541	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
14	rs72835933	chr17:16718541-16718542	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
15	rs543435270	chr17:16718542-16718543	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
16	rs76994548	chr17:16718545-16718546	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
17	rs78440060	chr17:16718551-16718552	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
18	rs117112929	chr17:16718583-16718584	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
19	rs532289530	chr17:16718620-16718621	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
20	rs566993323	chr17:16718681-16718682	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
21	rs559592372	chr17:16718730-16718731	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
22	rs2688029	chr17:16718768-16718769	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs548520658	chr17:16718774-16718775	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
24	rs567624303	chr17:16718855-16718856	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
25	rs530019949	chr17:16718904-16718905	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
26	rs550181106	chr17:16718934-16718935	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
27	rs74748972	chr17:16718952-16718953	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
28	rs570042503	chr17:16718958-16718959	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
29	rs538793442	chr17:16718960-16718961	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
30	rs558677551	chr17:16718968-16718969	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
31	rs565940412	chr17:16718988-16718989	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
32	rs552682577	chr17:16719155-16719156	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs554983699	chr17:16719158-16719159	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs2656362	chr17:16719160-16719161	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs186422689	chr17:16719183-16719184	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs556967003	chr17:16719242-16719243	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs62074110	chr17:16719260-16719261	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs2262180	chr17:16719264-16719265	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs545923980	chr17:16719351-16719352	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs559554399	chr17:16719358-16719359	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs528319063	chr17:16719362-16719363	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs542037447	chr17:16719369-16719370	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs561818001	chr17:16719397-16719398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs530874587	chr17:16719476-16719477	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs549903602	chr17:16719597-16719598	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs563701776	chr17:16719631-16719632	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs146054694	chr17:16719642-16719643	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs2628343	chr17:16719664-16719665	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs552267658	chr17:16719715-16719716	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs565905213	chr17:16719745-16719746	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:158)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD

Chromatin state (count:107 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:16716600-16723200	Weak transcription	Right Atrium	heart
2	chr17:16717200-16720000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr17:16717800-16719000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr17:16718000-16719000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
5	chr17:16718000-16719000	ZNF genes & repeats	Spleen	Spleen
6	chr17:16718600-16719200	Enhancers	A549	lung
7	chr17:16718600-16720600	Weak transcription	Placenta Amnion	Placenta Amnion
8	chr17:16719000-16719200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr17:16719000-16719200	Enhancers	NHEK	skin
10	chr17:16719000-16719400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr17:16719000-16723200	Weak transcription	Spleen	Spleen
12	chr17:16719000-16724000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr17:16719200-16720600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr17:16719200-16723600	Weak transcription	NHEK	skin
15	chr17:16719400-16720200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr17:16720200-16722400	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
17	chr17:16720600-16722200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr17:16720600-16723000	Strong transcription	Placenta Amnion	Placenta Amnion
19	chr17:16720600-16723200	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr17:16721400-16724600	Enhancers	Adipose Nuclei	Adipose
21	chr17:16721600-16723800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
22	chr17:16721800-16722000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr17:16722000-16722600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr17:16722000-16723200	Enhancers	Skeletal Muscle Male	skeletal muscle
25	chr17:16722000-16724800	Enhancers	Right Ventricle	heart
26	chr17:16722200-16723000	Bivalent Enhancer	Fetal Muscle Leg	muscle
27	chr17:16722200-16724200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr17:16722400-16722600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr17:16722400-16722800	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr17:16722400-16722800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
31	chr17:16722400-16723400	Enhancers	Skeletal Muscle Female	skeletal muscle
32	chr17:16722600-16723200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr17:16722600-16724400	Enhancers	Rectal Smooth Muscle	rectum
34	chr17:16722600-16724600	Enhancers	Breast Myoepithelial Primary Cells	Breast
35	chr17:16722600-16724800	Enhancers	Left Ventricle	heart
36	chr17:16722800-16723400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
37	chr17:16722800-16723800	Enhancers	HMEC	breast
38	chr17:16722800-16724000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
39	chr17:16722800-16725200	Transcr. at gene 5' and 3'	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr17:16722800-16725200	Enhancers	Esophagus	oesophagus
41	chr17:16723000-16723600	Weak transcription	Placenta Amnion	Placenta Amnion
42	chr17:16723000-16724800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr17:16723000-16724800	Enhancers	Fetal Heart	heart
44	chr17:16723000-16725200	Enhancers	Fetal Muscle Leg	muscle
45	chr17:16723200-16723400	Enhancers	Spleen	Spleen
46	chr17:16723200-16723800	Enhancers	Rectal Mucosa Donor 29	rectum
47	chr17:16723200-16724200	Enhancers	Rectal Mucosa Donor 31	rectum
48	chr17:16723200-16724200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
49	chr17:16723200-16724400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr17:16723200-16724400	Transcr. at gene 5' and 3'	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links